Selective boosting of tumor subvolumes

Wolfgang A. Tome, Jack F. Fowler

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Purpose and background: It is no longer considered mandatory to deliver a uniform dose to the tumor volume in radiotherapy. Non-uniform doses are unavoidable in brachytherapy and in stereotactic radiosurgery, with often good results. Deliberately non-uniform doses may increase tumor control probability (TCP) and enable steeper dose gradients outside the treated volume to be achieved. New methods of tumor imaging might show regions of specific activity or hypoxia which could be selectively targeted. This paper investigates by modeling the effect of boosting, by dose ratios up to 2, for a range of tumor subvolumes. Methods and Materials: A standard linear-quadratic algorithm was used to define the dose-response curve for tumors of various volumes (numbers of clonogenic cells), radiosensitivity (SF2), assumed slope (γ50) and dose for 50% tumor control (TCD50). Curves of tumor control probability (TCP) were constructed to show the increase of TCP, as a function of the ratio of boost dose to the TCD50, above the baseline 50% TCP, for a set of different proportions of tumor volume boosted. Results: Calculated values of TCP increased rapidly with both boost dose ratio and with proportion of volume boosted. The increase in TCP reached a plateau after boost dose ratios of 1.2-1.3, as has been noted before, except where very large proportions of tumor volume exceeding 90% were boosted. Quite large increases of TCP, to about 75%, could be achieved if the γ50 slope was steep, and especially in small tumors (having fewer cells). Radiosensitivity was not an independent factor because radiosensitive tumors had a low TCD50 and this was the baseline dose considered as unity. Conclusion: There were few situations where a boost dose ratio exceeding 1.3 appeared to be worthwhile or necessary. Significant increases of TCP, up from 50% to 75%, might therefore be achieved for a small increase in risk of necrosis, where a substantial proportion of tumor volume (60-80%) could be boosted.

Original languageEnglish (US)
Pages (from-to)593-599
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume48
Issue number2
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

tumors
dosage
Neoplasms
Tumor Burden
acceleration (physics)
proportion
Radiation Tolerance
radiation tolerance
Radiosurgery
Brachytherapy
slopes
necrosis
hypoxia
Necrosis
Radiotherapy
Cell Count
curves
cells
unity
radiation therapy

Keywords

  • Boosting
  • Gamma-50
  • Inhomogeneity
  • Modeling
  • Non-uniform doses
  • TCD50
  • TCP

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Selective boosting of tumor subvolumes. / Tome, Wolfgang A.; Fowler, Jack F.

In: International Journal of Radiation Oncology Biology Physics, Vol. 48, No. 2, 2000, p. 593-599.

Research output: Contribution to journalArticle

@article{9c47c9e4e7504733aeaea77168c4757d,
title = "Selective boosting of tumor subvolumes",
abstract = "Purpose and background: It is no longer considered mandatory to deliver a uniform dose to the tumor volume in radiotherapy. Non-uniform doses are unavoidable in brachytherapy and in stereotactic radiosurgery, with often good results. Deliberately non-uniform doses may increase tumor control probability (TCP) and enable steeper dose gradients outside the treated volume to be achieved. New methods of tumor imaging might show regions of specific activity or hypoxia which could be selectively targeted. This paper investigates by modeling the effect of boosting, by dose ratios up to 2, for a range of tumor subvolumes. Methods and Materials: A standard linear-quadratic algorithm was used to define the dose-response curve for tumors of various volumes (numbers of clonogenic cells), radiosensitivity (SF2), assumed slope (γ50) and dose for 50{\%} tumor control (TCD50). Curves of tumor control probability (TCP) were constructed to show the increase of TCP, as a function of the ratio of boost dose to the TCD50, above the baseline 50{\%} TCP, for a set of different proportions of tumor volume boosted. Results: Calculated values of TCP increased rapidly with both boost dose ratio and with proportion of volume boosted. The increase in TCP reached a plateau after boost dose ratios of 1.2-1.3, as has been noted before, except where very large proportions of tumor volume exceeding 90{\%} were boosted. Quite large increases of TCP, to about 75{\%}, could be achieved if the γ50 slope was steep, and especially in small tumors (having fewer cells). Radiosensitivity was not an independent factor because radiosensitive tumors had a low TCD50 and this was the baseline dose considered as unity. Conclusion: There were few situations where a boost dose ratio exceeding 1.3 appeared to be worthwhile or necessary. Significant increases of TCP, up from 50{\%} to 75{\%}, might therefore be achieved for a small increase in risk of necrosis, where a substantial proportion of tumor volume (60-80{\%}) could be boosted.",
keywords = "Boosting, Gamma-50, Inhomogeneity, Modeling, Non-uniform doses, TCD50, TCP",
author = "Tome, {Wolfgang A.} and Fowler, {Jack F.}",
year = "2000",
doi = "10.1016/S0360-3016(00)00666-0",
language = "English (US)",
volume = "48",
pages = "593--599",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Selective boosting of tumor subvolumes

AU - Tome, Wolfgang A.

AU - Fowler, Jack F.

PY - 2000

Y1 - 2000

N2 - Purpose and background: It is no longer considered mandatory to deliver a uniform dose to the tumor volume in radiotherapy. Non-uniform doses are unavoidable in brachytherapy and in stereotactic radiosurgery, with often good results. Deliberately non-uniform doses may increase tumor control probability (TCP) and enable steeper dose gradients outside the treated volume to be achieved. New methods of tumor imaging might show regions of specific activity or hypoxia which could be selectively targeted. This paper investigates by modeling the effect of boosting, by dose ratios up to 2, for a range of tumor subvolumes. Methods and Materials: A standard linear-quadratic algorithm was used to define the dose-response curve for tumors of various volumes (numbers of clonogenic cells), radiosensitivity (SF2), assumed slope (γ50) and dose for 50% tumor control (TCD50). Curves of tumor control probability (TCP) were constructed to show the increase of TCP, as a function of the ratio of boost dose to the TCD50, above the baseline 50% TCP, for a set of different proportions of tumor volume boosted. Results: Calculated values of TCP increased rapidly with both boost dose ratio and with proportion of volume boosted. The increase in TCP reached a plateau after boost dose ratios of 1.2-1.3, as has been noted before, except where very large proportions of tumor volume exceeding 90% were boosted. Quite large increases of TCP, to about 75%, could be achieved if the γ50 slope was steep, and especially in small tumors (having fewer cells). Radiosensitivity was not an independent factor because radiosensitive tumors had a low TCD50 and this was the baseline dose considered as unity. Conclusion: There were few situations where a boost dose ratio exceeding 1.3 appeared to be worthwhile or necessary. Significant increases of TCP, up from 50% to 75%, might therefore be achieved for a small increase in risk of necrosis, where a substantial proportion of tumor volume (60-80%) could be boosted.

AB - Purpose and background: It is no longer considered mandatory to deliver a uniform dose to the tumor volume in radiotherapy. Non-uniform doses are unavoidable in brachytherapy and in stereotactic radiosurgery, with often good results. Deliberately non-uniform doses may increase tumor control probability (TCP) and enable steeper dose gradients outside the treated volume to be achieved. New methods of tumor imaging might show regions of specific activity or hypoxia which could be selectively targeted. This paper investigates by modeling the effect of boosting, by dose ratios up to 2, for a range of tumor subvolumes. Methods and Materials: A standard linear-quadratic algorithm was used to define the dose-response curve for tumors of various volumes (numbers of clonogenic cells), radiosensitivity (SF2), assumed slope (γ50) and dose for 50% tumor control (TCD50). Curves of tumor control probability (TCP) were constructed to show the increase of TCP, as a function of the ratio of boost dose to the TCD50, above the baseline 50% TCP, for a set of different proportions of tumor volume boosted. Results: Calculated values of TCP increased rapidly with both boost dose ratio and with proportion of volume boosted. The increase in TCP reached a plateau after boost dose ratios of 1.2-1.3, as has been noted before, except where very large proportions of tumor volume exceeding 90% were boosted. Quite large increases of TCP, to about 75%, could be achieved if the γ50 slope was steep, and especially in small tumors (having fewer cells). Radiosensitivity was not an independent factor because radiosensitive tumors had a low TCD50 and this was the baseline dose considered as unity. Conclusion: There were few situations where a boost dose ratio exceeding 1.3 appeared to be worthwhile or necessary. Significant increases of TCP, up from 50% to 75%, might therefore be achieved for a small increase in risk of necrosis, where a substantial proportion of tumor volume (60-80%) could be boosted.

KW - Boosting

KW - Gamma-50

KW - Inhomogeneity

KW - Modeling

KW - Non-uniform doses

KW - TCD50

KW - TCP

UR - http://www.scopus.com/inward/record.url?scp=0034267722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034267722&partnerID=8YFLogxK

U2 - 10.1016/S0360-3016(00)00666-0

DO - 10.1016/S0360-3016(00)00666-0

M3 - Article

VL - 48

SP - 593

EP - 599

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -